Why the study?
Do beta-blockers reduce mortality in patients after myocardial infarction, including those with high-risk features?
Population
201,752 patients with myocardial infarction
Comparison
Beta-blockers vs Untreated patients (no beta-blockers)
Design
Cohort
Follow-up
2 years
Key result
Beta-blocker therapy after myocardial infarction was associated with reduced mortality across all subgroups, including a 40% reduction in uncomplicated, non-Q-wave, and COPD patients.
Authors
Loading...
May support beta-blocker consideration post-MI across subgroups including COPD; extends observational data but leaves open need for contemporary RCTs.
Cohort (n=201,752)
Yes
Do beta-blockers reduce mortality in patients after myocardial infarction, including those with high-risk features?
Beta-blocker therapy after myocardial infarction is associated with reduced mortality across all patient subgroups, including those with traditional relative contraindications such as heart failure, COPD, and advanced age.
Gottlieb et al. (1998) conducted a cohort in Myocardial infarction (n=201,752). Beta-blockers vs. Untreated patients was evaluated on Mortality during the two years after myocardial infarction. Beta-blocker therapy after myocardial infarction was associated with reduced mortality across all subgroups, including a 40% reduction in uncomplicated, non-Q-wave, and COPD patients.